Publication:
[Immunisation schedule of the Spanish Association of Paediatrics: 2020 recommendations].

dc.contributor.authorÁlvarez García, Francisco José
dc.contributor.authorCilleruelo Ortega, María José
dc.contributor.authorÁlvarez Aldeán, Javier
dc.contributor.authorGarcés-Sánchez, María
dc.contributor.authorGarcía Sánchez, Nuria
dc.contributor.authorGarrote Llanos, Elisa
dc.contributor.authorHernández Merino, Ángel
dc.contributor.authorIofrío de Arce, Antonio
dc.contributor.authorMerino Moína, Manuel
dc.contributor.authorMontesdeoca Melián, Abián
dc.contributor.authorNavarro Gómez, María Luisa
dc.contributor.authorRuiz-Contreras, Jesús
dc.contributor.authoren representación del Comité Asesor de Vacunas de la Asociación Española de Pediatría (CAV-AEP)
dc.contributor.authorComposición y filiación profesional de los miembros del Comité Asesor de Vacunas de la Asociación Española de Pediatría
dc.date.accessioned2023-02-08T14:39:05Z
dc.date.available2023-02-08T14:39:05Z
dc.date.issued2020
dc.description.abstractThe CAV-AEP annually publishes the immunisation schedule considered optimal for all children resident in Spain, taking into account the available evidence. The 2+1 schedule is recommended (2, 4, and 11 months) with hexavalent vaccines (DTPa-VPI-Hib-HB) and with 13-valent pneumococcal conjugate. A 6-year booster is recommended, preferably with DTPa (if available), with a dose of polio for those who received 2+1 schemes, as well as vaccination with Tdpa in adolescents and in each pregnancy, preferably between 27 and 32 weeks. Rotavirus vaccine should be systematic for all infants. Meningococcal B vaccine, with a 2+1 schedule, should be included in routine calendar. In addition to the inclusion of the conjugated tetravalent meningococcal vaccine (MenACWY) at 12 years of age with catch up to 18 years, inclusive, the CAV recommends this vaccine to be also included at 12 months of age, replacing MenC. Likewise, it is recommended in those over 6 weeks of age with risk factors or who travel to countries with a high incidence of these serogroups. Two-dose schedules for MMR (12 months and 3-4 years) and varicella (15 months and 3-4 years) will be used. The second dose could be applied as a tetraviral vaccine. Universal systematic vaccination against HPV is recommended, both for girls and boys, preferably at 12 years, and greater effort should be made to improve coverage. The 9 genotype extends coverage for both genders.
dc.identifier.doi10.1016/j.anpedi.2019.10.007
dc.identifier.essn2341-2879
dc.identifier.pmid31901289
dc.identifier.unpaywallURLhttps://doi.org/10.1016/j.anpedi.2019.10.007
dc.identifier.urihttp://hdl.handle.net/10668/14916
dc.issue.number1
dc.journal.titleAnales de pediatria
dc.journal.titleabbreviationAn Pediatr (Engl Ed)
dc.language.isoes
dc.organizationHospital Costa del Sol
dc.page.number52.e1-52.e10
dc.pubmedtypeJournal Article
dc.pubmedtypePractice Guideline
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectAdolescent
dc.subjectAdolescente
dc.subjectCalendario de vacunación
dc.subjectChild
dc.subjectEnfermedades inmunoprevenibles
dc.subjectImmunisation schedule
dc.subjectInfant
dc.subjectLactante
dc.subjectNiño
dc.subjectVaccine preventable diseases
dc.subjectVaccines
dc.subjectVacunas
dc.subject.meshAdolescent
dc.subject.meshBacterial Vaccines
dc.subject.meshChild
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshImmunization Schedule
dc.subject.meshInfant
dc.subject.meshMale
dc.subject.meshPediatrics
dc.subject.meshSocieties, Medical
dc.subject.meshSpain
dc.subject.meshViral Vaccines
dc.title[Immunisation schedule of the Spanish Association of Paediatrics: 2020 recommendations].
dc.title.alternativeCalendario de vacunaciones de la Asociación Española de Pediatría: recomendaciones 2020.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number92
dspace.entity.typePublication

Files